Hepatitis C, HIV Co-infection Impairs Cognitive Function

Women with both viruses have worse neurocognitive function than uninfected women

WEDNESDAY, Oct. 26 (HealthDay News) -- Women co-infected with HIV and the hepatitis C virus (HCV) run a greater risk of abnormal neuropsychological test results than other women, according to a study in the Oct. 14 issue of AIDS.

Jean L. Richardson of the University of Southern California, Los Angeles, and colleagues assessed the prevalence of abnormal neuropsychological results in 220 women enrolled in the Women's Interagency HIV Study, a study of disease progression in women living with HIV/AIDS.

Women with both HCV and HIV who were not taking antiretroviral drugs were seven times as likely to have neuropsychological impairment as women without HIV or HCV.

"This study has demonstrated the association of HCV with the risk of neurocognitive impairment in women living with HIV/AIDS and suggests that co-infection has an additive effect," the authors conclude.

Full Text (payment may be required)

Physician's Briefing